Group 1: Marubi Biotechnology - Marubi Biotechnology is expanding its audience on Douyin through targeted content delivery, leading to an increase in its traffic pool [1] - The company is undergoing organizational restructuring, optimizing its talent team and updating its compensation management system to support growth [1] - The strategic investment in the second quarter is expected to convert into results in the fourth quarter, with the "Lianhuo" brand entering a normal development phase and plans to continue launching new products in the second half of the year [1] Group 2: Tianfu Communication - In the first half of 2025, Tianfu Communication achieved revenue of 2.456 billion yuan, a year-on-year increase of 57.84%, and a net profit of 899 million yuan, up 37.46% [2] - The growth in active business is primarily driven by the increased delivery of high-speed active products, with the company continuously expanding its new customer base [2] - The company's gross margin has decreased due to changes in product structure, with an increased proportion of revenue from active products [2] Group 3: Plit - Plit reported significant growth in the first half of 2025, driven by a full order book in modified materials and the release of new production capacity [3] - The renewable energy segment saw a year-on-year revenue increase of 21.32%, supported by high demand for square batteries and an increase in orders for sodium-ion batteries [3] - The company is actively applying modified materials in the robotics sector, with some materials already being supplied in bulk to industrial robots [3]

Group 1: Marubi Biotechnology - Marubi Biotechnology is expanding its audience on Douyin through targeted content delivery, leading to an increase in its traffic pool [1] - The company is implementing organizational restructuring, optimizing its talent team, and upgrading its compensation management system to support growth [1] - The strategic investment in the second quarter is expected to convert significantly in the fourth quarter, with the "Lianhuo" brand entering a normal development phase and plans to continue launching new products in the second half of the year [1] - The three core product series account for over 70% of sales, indicating potential for further explosive growth [1] - The "Xiaojinzheng" series is enhancing customer purchase rates through synergistic effects, fostering consumption linkage between new and old customers [1] - The company is balancing investment in traffic and brand building while continuously promoting brand development [1] - The "Xiaohongbi" eye cream is performing exceptionally well in the market, with plans to gradually launch a series of products [1] - The company possesses core R&D capabilities and is leading the establishment of national industry standards for restructured collagen [1] Group 2: AVIC High-Tech - AVIC High-Tech is consolidating its main business while deepening its strategic layout in the low-altitude economy during the "14th Five-Year Plan" [2] - The company is advancing the research and industrialization of products such as honeycomb and composite structural components [2] - AVIC High-Tech has invested 9.17 billion in a project to enhance its capabilities in civil aviation composite components, specifically for large aircraft and G600 projects [2] - The Shenzhen subsidiary is collaborating with leading companies in the low-altitude economy, with some clients already initiating commercial operations [2] - The improvement in gross margin is attributed to changes in product structure, and new incubated businesses are expected to maintain reasonable gross margin levels [2] - The company anticipates significant improvement in cash collection in the second half of the year due to the maturity of bills received last year [2] - AVIC High-Tech is actively positioning itself in the large aircraft sector, with a significant expected increase in the application of composite materials [2] - R&D expenses have increased as projects are progressing as planned, with some costs being recognized in a timely manner [2]

Group 1 - The core viewpoint of the news is that Kaiming Investment has conducted research on Marubi Biotechnology, highlighting the company's strategies for growth and market performance [1] - Marubi Biotechnology is expanding its audience on Douyin through targeted content delivery, leading to an increase in its traffic pool [1] - The company is undergoing organizational restructuring, optimizing its talent team, and upgrading its compensation management system to support growth [1] Group 2 - Marubi's major product strategy and brand investment are ensuring sustained growth, with strategic investments in Q2 expected to convert in Q4 [1] - The "Lianhuo" brand has entered a normal development phase, and the company plans to continue launching new products in the second half of the year [1] - The three core product series account for over 70% of sales, indicating potential for further explosive growth [1] Group 3 - The "Xiaojin Needle" series is enhancing customer purchase rates through synergistic effects, creating consumption linkage between new and existing customers [1] - The company is balancing investment in traffic and brand building while continuously advancing brand development [1] - The "Xiaohongbi" eye cream has shown excellent market performance, with plans for a gradual rollout of a series of products [1] Group 4 - Marubi possesses core R&D capabilities and is leading the establishment of national industry standards for restructured collagen [1]

Summary of the Beauty Industry Conference Call Industry Overview - The beauty industry experienced a total sales growth of 5.2% during the 618 shopping festival, with total sales reaching approximately 855.6 billion yuan, a 15.2% increase year-on-year. The event duration was extended to 36 days, leading to a slight decline in average daily sales compared to the previous year [2][14]. Key Brands and Performance - **Polaire**: Achieved significant sales on Tmall and Douyin, with a GMV of 4.5 billion yuan on Douyin in 2025, facing some growth pressure but maintaining positive growth on Tmall [11]. - **Mao Geping**: Experienced a remarkable growth rate of 55%-60% on Douyin, driven by key products like caviar masks and foundation. The skincare category on Tmall also saw a growth rate of about 60% [5]. - **Perfect Diary**: Notable growth on Douyin attributed to new products like the small gold needle series and creams, with a growth rate of approximately 40% on Tmall [6]. - **Han Shu**: Maintained its leading position on Douyin with a growth rate of about 20%. The brand reduced its live broadcast ratio to 15% but still achieved good growth, indicating effective product card and self-broadcasting strategies [7][8]. - **Wenona**: Achieved a GMV close to 200 million yuan on Douyin, with a year-on-year growth rate of 20% in 2025, reflecting effective management changes [9][10]. - **Caitang**: Experienced over 100% growth on Douyin and 40-50% growth on Tmall, showing significant improvement under new management [12]. - **Kefumei**: Achieved a GMV of 270 million yuan on Douyin during the festival, with a year-on-year growth of 20%. Despite a decline in daily sales due to public sentiment issues, the brand's product quality remained unaffected [13]. Market Dynamics - The beauty and skincare categories performed exceptionally well, with Tmall's top five brands being Polaire, Lancôme, L'Oréal, Estée Lauder, and Shiseido [3][4]. - The overall growth of the beauty industry met expectations, with Tmall and Douyin continuing to support beauty products [14]. - Brands like Shangmei and Ruoyuchen are highlighted as potential investment opportunities, with Ruoyuchen's flagship store achieving over 70 million yuan GMV on Douyin during the festival [14]. Investment Insights - The beauty industry is considered suitable for investment due to valuation adjustments, particularly for companies like Juzhi Biology and Runben, which are expected to see significant growth [14].